Multiple myeloma: unplanned diagnostic pathways and association with risk factors and survival - a nationwide register-based cohort study in Denmark
- Linda Aagaard Rasmussen 1, Peter Vedsted 2,3, Henry Jensen 4, Henrik Frederiksen 5, Tarec Christoffer El-Galaly 5,6,7, Ida Bruun Kristensen 5, Line Flytkjaer Virgilsen 2
- Linda Aagaard Rasmussen 1, Peter Vedsted 2,3, Henry Jensen 4
- 1Research Unit for General Practice, Aarhus, Denmark. linda.rasmussen@ph.au.dk.
- 2Research Unit for General Practice, Aarhus, Denmark.
- 3Department of Clinical Medicine, University Clinic for Innovative Patient Pathways, Aarhus University, Aarhus, Denmark.
- 4Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus, Denmark.
- 5Department of Haematology, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
- 6Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
- 7Department of Medicine, Solna, Division of Clinical Epidemiology, Karolinska Institute, Stockholm, Sweden.
- 0Research Unit for General Practice, Aarhus, Denmark. linda.rasmussen@ph.au.dk.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multiple myeloma is often diagnosed unexpectedly, particularly in patients with high comorbidity or advanced disease. Diagnoses through unplanned pathways are linked to poorer survival outcomes, highlighting the need for earlier detection strategies.
Area Of Science
- Hematology
- Oncology
- Epidemiology
Background
- Multiple myeloma frequently presents with non-specific symptoms, leading to delayed diagnosis.
- A significant proportion of multiple myeloma cases are diagnosed through unplanned, often acute, care pathways.
Purpose Of The Study
- To investigate the characteristics of multiple myeloma diagnoses within unplanned diagnostic pathways.
- To explore the association between unplanned diagnosis and patient factors, disease profile, and survival outcomes.
Main Methods
- A nationwide, register-based study was conducted in Denmark from 2014 to 2018.
- Patients diagnosed with multiple myeloma were categorized based on whether their diagnosis occurred via an unplanned pathway (acute admission within 30 days prior).
- Unplanned pathways were compared against all other diagnostic pathways.
Main Results
- 32% of 2,213 multiple myeloma patients were diagnosed via an unplanned pathway.
- Factors associated with unplanned diagnosis included high comorbidity (Charlson Comorbidity Index 3+), no prior cancer history, few general practitioner visits, myeloma complications, high-risk cytogenetics, and advanced stage.
- Patients diagnosed via unplanned pathways exhibited inferior survival (hazard ratio 1.44), though this was not significant for long-term survivors.
Conclusions
- High comorbidity, advanced disease, and complications are linked to unplanned multiple myeloma diagnoses.
- Unplanned diagnostic pathways are associated with reduced survival for multiple myeloma patients.
- Strategies promoting earlier detection and reducing unplanned diagnoses may improve patient survival.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

